TRDA Equities

Intellia Therapeutics Faces a Setback as Q2 2024 Earnings and Revenues Miss Estimates Aug 10, 2024

Nektar Therapeutics NKTR Faces Q2 Earnings Shortfall, Despite Revenue Surge Aug 10, 2024

Entrada Therapeutics' Notable Surge: Analyzing The Continued Upwards Trajectory Jul 13, 2024

NextCure NXTC Adjusts Focus, Discontinues Development of NC762 Amid Stock Decline Dec 16, 2023

Biotech Sector Update: BMY Suffers Setback, while Other Stocks Offer News Nov 23, 2023